Campostrini F., Di Marco A.
Observation of bone metastases from breast cancer //
Raus. — 1984. — V. 9(2). — P.109 114.
Canellos G.P.
Combination chemotherapy for metastatic breast carcinoma: prospec
tive comparison of multiple drug therapy with L phenylalanine mustard // Cancer. —
1976a. — V. 38. — P. 1882 1886.
Canellos G.P.
Combination therapy for advanced breast cancer: response and effect
on survival // Ann. Intern. Med. — 1976b. — V. 84. — P. 389 392.
Carmichael J., Possinger K., Phillip P.,
è ñîàâò. Advanced breast cancer: a phase
II trial with gemcitabine // J. Clin. Oncol. — 1995. — V. 13. — P. 2731 2736.
Carr D.B., Carr J.M.
In: Bone metastases monitoring and treatment. Eds. B. A Stoll,
S. Parbhoo. — New York: Raven Press. — 1985. — P. 375 394.
Carty N.G., Foggiti A., Hamilton C.R.
Patters of clinical metastases in breast cancer
and analysis of 100 patients // Eur. J. Surg. Oncol. — 1995. — V. 21 (6). — P. 607 608.
Cascinu S., Casadei V., Del Ferro E., Alessandroni P., Catalano G.
Pamidronate in
patients with painful bone metastases, who failed initial treatment with hormones and/or
chemotherapy // Support Care Cancer 1996. — V. 4(1). — P. 31 33.
Cavailles V., Garcia M., Roshefort H.
Regulation of catepsin D and P 52 gene expres
sion by growth factors inMCF— 7 human breast cancer cells // Mol. Endocrinol. — 1989. —
V. 3. — P. 552 558.
Ceci G., Passalaqua R,. Bisagni G., Bella M., Ñoccini G.
Aminiglutethimide in
advanced breast cancer // Tumori. — 1985. — V. 71. — P. 483 489.
Chan P., Cohen L.
Effect of dieraty fat antiestrogen and antiprolactin on the devel
opment of mammary tumor in rats // J. Nation. Cancer Inst. — 1974. –V. 52. — P. 25 31.
Chan Y., Chan K., Lam W., Metreweli C.
Comparison of whole body MRI and
radioisotope bone scintigram for skeletal metastases detection // Chin. Med .J. (Engl). —
1997. — V. 110(6). — P. 485 489.
Charkes N., Malmud L., Daswell T.
è ñîàâò. Preoperative bone scans // J.A.M.A. —
1975. — V. 233. — P. 516 518.
Chaudary M.A., Maisey M.N., Shaw P.J, Rubens R.D., Hayward J.L
. Sequental bone
scanning and chest radiographs in the postoperative management of early breast cancer //
Br. J. Surg. — 1983. — V. 70. — P. 517 518.
Chlebowski R.T.
Survival of patients with metastatic breast cancer treated with either
combination or sequential chemotherapy // Cancer Res. — 1979. — V. 39. — P. 4503
4510.
Chlebowski R.T., Block J.B.
Chemotherapy of bone metastasis // In: Bone metas
tases. Eds.Weiss L., Gilbert H.A. –Boston: G.K.Hall. — 1981. — P. 312 324.
Citrin D., Bessent R., Brungart L.
Early detection of metastatic breast cancer using
new bone scanning agents // Proc. Soc. Med. — 1975. — V. 68. — P.386 387.
Citrin D.L., Furnival C.M., Bessent R.G., Greig W.R., Bell G., Blumgart L.H.
Radioactive technetium phosphate bone scanning in preoperative assessment and follow
up study of patients with primary carcinoma of the breast // Surg. Gynecol. Obstet. —
1976 V. 143. — P. 360 364.
Citrin D.L., Bessent R.G., Greig W.R.
A comparison of sensitivity and accuracy of the
Tc99m phospate bone scan and skeletal radiograph in the diagnosis of bone metastases //
Clin. Radiol. — 1977. — V. 28. — P. 107 117.
Civardi G., Livraghi T., Colombo P., Fornari F., Cavanna L., Buscarini L.
Lytic bone
lesions suspected for metastasis: ultrasonically guided fine needle aspiration biopsy // J.
Clin. Ultrasound 1994. — V. 22(5). — P. 307 311.
220
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
